HGF/MET-dependent nitric oxide release by neutrophils promotes cancer cell killing in many tumors, including fibrosarcoma, colon cancer, lung cancer, melanoma, and hepatocellular carcinoma. This evidence concerns the gene HGF and malignant colon neoplasm.